+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Primitive Neuroectodermal Tumors (PNET) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Pre Book Price: $ 5216

Original Price: $ 5795

Primitive neuroectodermal tumors (PNET) are highly malignant group of neoplasm of soft tissue that affects both children and adults. These malignant tumors are small round cells with neuroectodermal origin affecting soft tissues and bones rapidly. PNET was first described by Stout in 1918 and were thought to rise from the nerves. Peripheral primitive neuroectodermal tumors (pPNETs) are classified in the Ewing family of tumors (EFTs). Both these tumors have similar genetic alterations with different manifestations, and so are indistinguishably referred in the medical literature. Soft tissue tumors are associated prominently with peripheral primitive neuroectodermal tumors, while Ewing sarcoma is associated with bone tumor. These primitive neuroectodermal tumors have various clinical and pathological characteristics similar to many other types of small and round tumors. Hence, Batsakis et al in 1996 classified PNET family into three types based on the origin of tumor. The three types of PNET are CNS primitive neuroectodermal tumors (derived from the central nervous system), neuroblastoma (derived from autonomic nervous system), and peripheral primitive neuroectodermal tumors (originate from tissues other than autonomic or central nervous system).

Multidisciplinary therapeutic options are utilized for the treatment of PNET including surgery, chemotherapy, radiation therapy, and ventriculoperitoneal shunt. Surgery is carried out primarily for diagnosis and then for tumor removal. Removal of tumor is usually possible if it is supratentorial, and is less frequent in case of spine or pineal region. Radiation therapy is recommended if the tumor is not completely eradicated or if it reappears. Radiation therapy is followed by chemotherapy in order to interfere with growth or reproduction of the cancer. Ventriculoperitoneal shunt is a bypass, wherein a tubing is placed in the brain area in order to drain excess cerebrospinal fluid to space into the abdomen. Endoscopic third ventriculostomy is necessary in case of hydrocephalus (swelling of the brain).

The malignant nature of tumor is a major driver of the primitive neuroectodermal tumors treatment market owing to the recommended use of combination of therapies to combat aggressive nature of tumor. Recent advances in molecular diagnosis and cancer therapeutic combination treatments is expected to boost the growth of the primitive neuroectodermal tumors treatment market during the forecast period. Threat of drug failure, severe side effects of therapeutics, and high cost of research & development of better therapeutic options are expected to restrain the global primitive neuroectodermal tumors treatment market during the forecast period. However, rise in government funds and increase in awareness among the population about fatal diseases in emerging nations are expected to support the growth of the global primitive neuroectodermal tumors treatment market.

The global primitive neuroectodermal tumors treatment market can be segmented based on tumor type, treatment type, distribution channel, and region. In terms of tumor type, the market can be categorized into CNS primitive neuroectodermal tumors, neuroblastoma, and peripheral primitive neuroectodermal tumors. Based on treatment type, the global primitive neuroectodermal tumors treatment market can be classified into surgery, chemotherapy, radiation therapy, ventriculoperitoneal shunt, and others. In terms of distribution channel, the market can be divided into hospital pharmacies, drug stores, online pharmacies, and others. Based on region, the global primitive neuroectodermal tumors treatment market can be categorized into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa.

Major players dominating the global primitive neuroectodermal tumors treatment market include Eli Lilly and Company, Novartis AG, Pfizer, Sanofi, GlaxoSmithKline plc, and Merck & Company.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.


Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top